William Blair Upgrades 10X Genomics (TXG) to Outperform
William Blair analyst Matt Larew upgraded 10X Genomics (NASDAQ: TXG) from Market Perform to Outperform.The analyst commented, "In connection with ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
